IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

Bo Hu, Mincheng Yu, Xiaolu Ma, +18

Cancer Discovery

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway

Chenhao Zhou, Chunxiao Liu, Wenjie Liu, +15

Theranostics

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma

Jian Wang, Ao Huang, Yupeng Wang, +4

Annals of Translational Medicine

NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells

Bo Hu, Guangyu Ding, Pei‐Yao Fu, +11

Journal of Hematology & Oncology

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy

Mincheng Yu, Zheng Chen, Qiang Zhou, +21

Journal of Hepatology

New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer

Pei‐Yao Fu, Bo Hu, Xiaolu Ma, +12

Journal of Cellular Biochemistry

High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection

Jialei Sun, Chenhao Zhou, Qianni Ma, +8

Journal of Cancer

Improving bowel preparation for colonoscopy with a smartphone application driven by artificial intelligence

Yan Zhu, Danfeng Zhang, Huili Wu, +18

npj Digital Medicine

Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axis

Wei‐Guo Tang, Bo Hu, Haixiang Sun, +9

Oncotarget

The mRNA–miRNA–lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma

Bo Hu, Xiaolu Ma, Pei‐Yao Fu, +8

Genomics Proteomics & Bioinformatics